Skip to content

Aurinia study interim results boost shares

June 16, 2017

Shares of Aurinia Pharmaceuticals Inc
AUPH 1.52%
, a clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity, ticked higher by more than 3 percent early Friday morning after the company presented results from an ongoing study.

Aurinia presented remission data from a global Phase 2B AURA-LV (AURA) study in lupus nephritis during the Annual European Congress of Rheumatoloty in Madrid.

The company’s data showed treatment with a low dose of voclosporin demonstrated a statistically improved efficacy over the control arm at both the 24- and 48-week periods. Moreover, data showed a doubling of remission rates at the 48-week period versus the control arm of 49 percent versus 24 percent.

In fact, among patients who received a low dose of voclosporin and achieved complete remission at 24 weeks, 100 percent of those remained in complete remission at 48 weeks, which establishes the durability of clinical response.

“Not only have more patients on voclosporin achieved complete remission, but they have done so faster. Patients on low-dose voclosporin are also maintaining remission for a longer duration — nearly twice that of the control group on average,” stated Vladimir A. Dobronravov, MD, PhD, DSc, a clinical investigator for the study. “The quicker we can bring patients into remission and keep them there, the more likely we are to delay or even prevent the deleterious effects of prolonged inflammation which can lead to irreversible kidney damage.”

http://bit.ly/2sItskJ

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: